OR WAIT null SECS
November 16, 2007
Company and People Notes: BASF raises prices on excipients; Verus Pharmaceuticals appoints president and CEO; more.
November 15, 2007
A company has raised ?700000 to assist in the development of treatments for antibiotic resistant bacteria.
November 08, 2007
Pfizer's Lipitor patent revoked in Germany, promotions at Charles River Labs, more.
November 02, 2007
Natural gums and mucilage have been widely explored as pharmaceutical excipients. The goal of this study was to extract mucilage from the leaves of Aloe barbadensis Miller and to study its functionality as an excipient in pharmaceutical sustained-release tablet formulations.
November 01, 2007
The crystalline structure of pharmaceutical solids can sometimes be altered during processing. X-ray powder diffraction and near infrared spectroscopy can be used to determine the amorphous and crystalline content of a model substance. The two techniques' precision, accuracy, detection limit and the speed of analysis are compared.
Company Notes: Gibraltar expands facilities; Allozyne appoints new president and CEO, more.
October 24, 2007
Company and People Notes: ImClone, BMS, and Merck form agreement; CRI Worldwide names new CEO, more.
October 18, 2007
Company and People Notes: Orexo acquires Biolipox, Avalon cofounder resigns, more...
October 17, 2007
An exclusive licence agreement has been signed to develop a new oral treatment for rheumatoid arthritis (RA), a condition that affects approximately 165 million people.
October 11, 2007
Company and People Notes: Novartis and MIT to study continuous processing, GSK appoints Andrew Witty as CEO, more.